A Trial to Evaluate the Efficacy and Safety of Methoxyetomidate Hydrochloride for Injection (ET-26) for the Induction of General Anesthesia in Elective Surgery Subjects

This study is testing a new medicine called *Methoxyetomidate Hydrochloride* (ET-26) to see if it can safely help people fall asleep for surgery, just like another medicine called *Etomidate*. This is a *Phase III* trial, which means it's one of the last steps before a medicine might be sold in stores. The people in the study will be randomly chosen to get either ET-26 or Etomidate, and neither they nor the doctors will know which one they got (this is called "double-blind"). 💤

To join, you must be between 18-70 years old, have surgery that isn’t an emergency and involves non-cardiothoracic or non-extracranial areas, and need general anesthesia with a breathing tube. You also need to be generally healthy, with normal blood pressure, breathing, and heart rate. If you have a history of bad reactions to anesthesia or certain medical conditions, you cannot join.

• **Compensation**: Participants might be compensated for their time and travel.
• **Duration**: It lasts for the duration of the surgery and immediate recovery.
• **Risks**: There may be risks related to anesthesia or the new drug.